filmov
tv
Rare Variants and Drug Target Discovery
Показать описание
Presented by Alan R. Shuldiner, MD (Regeneron) at the PGRN Symposium on October 15, 2018 in San Diego, CA.
PGRN Hub
PGRN
PGRN Hub
Pharmacogenomics
Pharmacogenomics Research Network
Рекомендации по теме
Rare Variants and Drug Target Discovery
Discussion with Dr Veera M. Rajagopal about 'Rare variants and drug targets discovery'
Are there genetic variants in or around my drug target?
Extremely rare gene variants and AMD
Genetics, Genomics, and Drug Discovery - Lon Cardon
[William Reay] Advancing the use of GWAS for drug repurposing and precision treatment
Frederick Dewey - Natural Human Gene Knockouts and the Discovery of New Drug Targets
Public Health Impact of Rare Variants
Gerard Schellenberg - What Genetics and Rare-Variant Studies Have Told Us About Alzheimer's Dis...
Rare variant association tests in large-scale biobanks and cohorts
Using GWAS and Sequence Data to Identify and Validate Drug Targets
Impact of Human Genetics on Drug R&D
Drug Development Genotyping Array | Illumina Webinar
MPG Primer: Rare Variant Interpretation (2024)
Drug Targets, druggability, and efficacy
Advancements in Colorectal Cancer: Detecting and Addressing Rare Genetic Variants
Dr. Volker Lauschke
Harnessing Genetics to Identify Druggable Targets and Causes of Off-Target Cardiotoxicity
[Zilin Li] STAARpipeline: a framework for detecting noncoding rare variant associations of WGS study
GenQA Molecular Pathology: Pathogenicity of somatic sequence variants on 24th May 2021
GENE-BASED ASSOCIATION ANALYSIS OF SURVIVAL ASSOCIATED RARE VARIANTS IN ALS
Discovering Variants Conferring Risk for Common Diseases - Michael Boehnke
Neurology Grand Rounds: Precision Medicine & Drug Discovery
Xihong Lin | Overview of Rare Variant Analysis of Whole Genome ... | CGSI 2022